Discovery of Potent Cytotoxic Ortho-Aryl Chalcones as New Scaffold Targeting Tubulin and Mitosis with Affinity-Based Fluorescence
Authors:
- 25 July 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (15) , 6364-6382
Abstract
A series of new ortho-aryl chalcones have been designed and synthesized. Many of these compounds were found to exhibit significant antiproliferation activity toward a panel of cancer cell lines. Selected compounds show potent cytotoxicity against several drug resistant cell lines including paclitaxel (Taxol) resistant human ovarian carcinoma cells, vincristine resistant human ileocecum carcinoma cells, and doxorubicin resistant human breast carcinoma cells. Further investigation revealed that active analogues could inhibit the microtubule polymerization by binding to colchicine site and thus induce multipolar mitosis, G2/M phase arrest, and apoptosis of cancer cells. Furthermore, affinity-based fluorescence enhancement was observed during the binding of active compounds with tubulin, which greatly facilitated the determination of tubulin binding site of the compounds. Finally, selected compound 26 was found to exhibit obvious in vivo antitumor activity in A549 tumor xenografts model. Our systematic studies implied a new scaffold targeting tubulin and mitosis for novel antitumor drug discovery.Keywords
Funding Information
- National Natural Science Foundation of China (30973619, 81172931)
- Fundamental Research Funds for the Central Universities of China (09ykpy66)
This publication has 46 references indexed in Scilit:
- Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic AgentsJournal of Medicinal Chemistry, 2013
- Design, Synthesis, and Biological Evaluation of (E)-N-Aryl-2-arylethenesulfonamide Analogues as Potent and Orally Bioavailable Microtubule-Targeted Anticancer AgentsJournal of Medicinal Chemistry, 2013
- Drugs that target dynamic microtubules: A new molecular perspectiveMedicinal Research Reviews, 2011
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of β-tubulin at Cys 12 and suppression of microtubule dynamicsMolecular Cancer Therapeutics, 2009
- Microtubule dynamics as a target in oncologyCancer Treatment Reviews, 2009
- Assembly dynamics of microtubules at molecular resolutionNature, 2006
- Microtubules as a target for anticancer drugsNature Reviews Cancer, 2004
- Structural Insights into Microtubule FunctionAnnual Review of Biophysics, 2001
- Tubulin structure: insights into microtubule properties and functionsCurrent Opinion in Structural Biology, 1998